Novavax, Inc. (NVAX) Reports In-Line Q2 EPS
Tweet
Share
E-mailGet Alerts NVAX Hot Sheet
Price: $9.00 --0%
Revenue Growth %: -78.2%
Financial Fact:
Net loss: -66.25M
Today's EPS Names:
CRWS, MEI, PODC, More
Revenue Growth %: -78.2%
Financial Fact:
Net loss: -66.25M
Today's EPS Names:
CRWS, MEI, PODC, More
Join SI Premium – FREE
Novavax, Inc. (NASDAQ: NVAX) reported Q2 EPS of ($0.05), in-line with the analyst estimate of ($0.05). Revenue for the quarter came in at $7.1 million versus the consensus estimate of $6.68 million.
For earnings history and earnings-related data on Novavax, Inc. (NVAX) click here.
For earnings history and earnings-related data on Novavax, Inc. (NVAX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Cerebras Q1 EPS miss sends shares down 9% after-hours
- BMO Capital Upgrades CES Energy Solutions Corp. (CEU:CN) (CESDF) to Outperform
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
